STOCK TITAN

Surmodics, Inc. (SRDX) EPS by Year

SRDX

Surmodics, Inc. lost $0.82 per diluted share in fiscal year 2024. This represents a decrease of 645.5% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $1.24 per diluted share. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Surmodics, Inc. has filed alongside them.

FY2024 annual
EPS (Diluted) -$0.82
YoY -645.5%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SRDX EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-K
EPS (Diluted)-$1.24-$0.82-645.5%-$0.11+94.4%-$1.96-753.3%$0.30+275.0%$0.08-85.5%$0.55+261.8%-$0.34-217.2%$0.29-61.8%$0.76-15.6%$0.90+3.4%$0.87-15.5%$1.03+74.6%$0.59+155.7%-$1.06+12.4%-$1.21

TTM is the trailing twelve months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

SRDX EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-K
EPS (Diluted)-$0.37+30.2%-$0.36-1900.0%-$0.26-333.3%-$0.25-152.1%-$0.53-201.9%$0.02+103.6%-$0.06+89.3%$0.48+145.3%$0.52+226.8%-$0.55-89.7%-$0.56-180.0%-$1.06-5200.0%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Surmodics, Inc. financials

Frequently Asked Questions

What was Surmodics, Inc.'s diluted earnings per share in fiscal year 2024?

Surmodics, Inc. lost $0.82 per diluted share in fiscal year 2024.

How fast is Surmodics, Inc.'s diluted earnings per share growing?

Surmodics, Inc. (SRDX) diluted earnings per share fell by 645.5% year over year, from -$0.11 to -$0.82 in fiscal year 2024.

What is Surmodics, Inc.'s diluted earnings per share over the last twelve months?

Surmodics, Inc. (SRDX) reported a loss of $1.24 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Surmodics, Inc. (SRDX) diluted earnings per share went from -$1.21 in fiscal year 2010 to -$0.82 in fiscal year 2024.

Surmodics, Inc. (SRDX) reported -$0.37 in diluted earnings per share in Q3 2025. This represents an increase of 30.2% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Surmodics, Inc. (SRDX) reported on that line in every period on record.